Employee health and corporate innovation: Evidence from medical cannabis legalisation

Linh Thompson

Accounting and Finance, 2024, vol. 64, issue 4, 3927-3950

Abstract: We study the effects of employee health on corporate innovation by exploiting staggered medical cannabis legalisation across states from 1995 to 2020. Medical cannabis legalisation increases medical access, thereby significantly influences employee health. Using a difference‐in‐differences empirical design, we find that firms became more innovative after their states legalised medical cannabis use. In particular, we show that firms produced more patents, generated more patents with significant impacts, and attained higher patent value following the passage of bills to legalise medical cannabis. We identify a possible mechanism through which employee health spurs innovation: lower worker turnover. Lower worker turnover encourages firm‐specific human capital investments and facilitates inter‐generational knowledge transfer. Taken together, our findings support the hypotheses that medical cannabis legalisation improves employee health, overall well‐being and their innovative capacities.

Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1111/acfi.13287

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bla:acctfi:v:64:y:2024:i:4:p:3927-3950

Ordering information: This journal article can be ordered from
http://www.blackwell ... bs.asp?ref=0810-5391

Access Statistics for this article

Accounting and Finance is currently edited by Robert Faff

More articles in Accounting and Finance from Accounting and Finance Association of Australia and New Zealand Contact information at EDIRC.
Bibliographic data for series maintained by Wiley Content Delivery ().